These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20648222)

  • 1. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.
    Smith SM; Uslaner JM; Hutson PH
    Open Med Chem J; 2010 May; 4():3-9. PubMed ID: 20648222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
    Szilágyi B; Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
    Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
    Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia.
    Ferraris DV; Tsukamoto T
    Curr Pharm Des; 2011; 17(2):103-11. PubMed ID: 21361869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
    Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
    Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
    Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
    Sacchi S; Rosini E; Pollegioni L; Molla G
    Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
    Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
    Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.
    Boks MP; Rietkerk T; van de Beek MH; Sommer IE; de Koning TJ; Kahn RS
    Eur Neuropsychopharmacol; 2007 Sep; 17(9):567-72. PubMed ID: 17250995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
    Kuo CY; Lin CH; Lane HY
    CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
    Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
    Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
    Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
    FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luvadaxistat: A Novel Potent and Selective D-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
    Fradley R; Goetghebeur P; Miller D; Burley R; Almond S; Gruart I Massó A; Delgado García JM; Zhu B; Howley E; Neill JC; Grayson B; Gaskin P; Carlton M; Gray I; Serrats J; Davies CH
    Neurochem Res; 2023 Oct; 48(10):3027-3041. PubMed ID: 37289348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
    Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
    J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
    Williams M
    Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.
    Rojas C; Alt J; Ator NA; Thomas AG; Wu Y; Hin N; Wozniak K; Ferraris D; Rais R; Tsukamoto T; Slusher BS
    Neuropsychopharmacology; 2016 May; 41(6):1610-9. PubMed ID: 26471255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies.
    Sacchi S; Cappelletti P; Murtas G
    Front Mol Biosci; 2018; 5():55. PubMed ID: 29946548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice.
    Rais R; Thomas AG; Wozniak K; Wu Y; Jaaro-Peled H; Sawa A; Strick CA; Engle SJ; Brandon NJ; Rojas C; Slusher BS; Tsukamoto T
    Drug Metab Dispos; 2012 Nov; 40(11):2067-73. PubMed ID: 22837388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of D-Amino Acid Oxidase (
    Jagannath V; Marinova Z; Monoranu CM; Walitza S; Grünblatt E
    Front Neuroanat; 2017; 11():31. PubMed ID: 28428746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human D-Amino Acid Oxidase: Structure, Function, and Regulation.
    Pollegioni L; Sacchi S; Murtas G
    Front Mol Biosci; 2018; 5():107. PubMed ID: 30547037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.